HYLORIS
Live / Registered — Registered (as of 21 Jan 2025)
What this means for you
Registered since 21 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97401213
- Registration number
- 7656999
- Mark type
- Stylized text
- Filed
- 09 May 2022
- Published for opposition
- 03 Dec 2024
- Registered
- 21 Jan 2025
- Attorney of record
- Clifford D Hyra
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceuticals; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of cardiovascular and cardiopulmonary diseases and disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; none of the aforementioned for the treatment of non-cardiological inflammatory disorders
- Class 040 — Treatment of materials: Custom manufacture of cardiovascular pharmaceuticals and medicines for treatment of cardiovascular diseases by pharmaceutical compounders; providing technical information in the field of pharmaceutical manufacturing of cardiovascular pharmaceuticals; biomanufacturing for others, namely, manufacturing of cardiovascular pharmaceuticals using biological organisms in the manufacturing process
- Class 042 — Scientific and technological services: Pharmaceutical research and development services in the field of cardiovascular and cardiopulmonary disease and disorders; Development of cardiovascular pharmaceutical preparations and medicines for the treatment of cardiovascular diseases; cardiovascular pharmaceutical products development; Laboratory research services in the field of pharmaceuticals and new products, namely, cardiovascular pharmaceutical and biotechnological products in the nature of cardiovascular pharmaceuticals; conducting early evaluations in the field of new cardiovascular pharmaceuticals; testing, inspection and research of cardiovascular pharmaceuticals; research and development in the biotechnology fields in relation to cardiovascular and cardiopulmonary diseases and disorders; technical consulting services in the fields of pharmaceutical research and development, biotechnology; technical consulting services in the field of scientific laboratory services, namely, laboratory testing, diagnostics; all the aforementioned in relation to cardio vascular and cardiopulmonary diseases and disorders
Owner
- Hyloris Pharmaceuticals SA, Liège, BE
- Hyloris Pharmaceuticals SA, Liège, BE
- Hyloris Pharmaceuticals SA, Liège, BE
Prosecution history
- 21 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Aug 2024 — NON-FINAL ACTION E-MAILED
- 09 Aug 2024 — NON-FINAL ACTION WRITTEN
- 16 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Jul 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED